v3.22.1
UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2022
Mar. 31, 2021
Revenue $ 3,575 $ 434
Operating expenses    
Research and development (36,752) (24,506)
General and administrative (16,804) (13,817)
Total operating expenses (53,556) (38,323)
Operating loss (49,981) (37,889)
Interest income 338 425
Other income (expense), net 12 (1)
Loss before income tax expense (49,631) (37,465)
Income tax expense (634) (298)
Net loss attributable to ordinary shareholders $ (50,265) $ (37,763)
Net loss per ordinary share    
Basic (in dollars per share) $ (0.05) $ (0.04)
Diluted (in dollars per share) $ (0.05) $ (0.04)
Weighted average shares outstanding:    
Basic (in shares) 940,029,247 931,088,810
Diluted (in shares) 940,029,247 931,088,810
Development revenue    
Revenue $ 3,575 $ 434

Source